JUN and COVID-19: The upregulation of JUN (Jun proto-oncogene, AP-1 transcription factor subunit) is prominently observed in the pathogenesis of severe COVID-19 patients with the development of viral infections and immunological abnormalities by T-cell hyperactivation [21].